Companies: 10,795·Total market cap: $144.5T
ProPhase Labs, Inc.

ProPhase Labs, Inc.

PRPHNASDAQHealthcare● Active
$0.10
$-0.01(-9.09%)
Market Cap$473701
P/E Ratio—
52W High$6.7
52W Low$0.07
Overview

ProPhase Labs, Inc. (PRPH) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

PRPH · net income · updated Jun 9, 2026

Core profitability metrics

Net income was −$14.7M for FY2025 (fiscal year ending 2025-12-31), up 72.4% year-over-year. Net profit margin was -339.3%. Based on available data, ProPhase Labs, Inc. has been profitable since at least 2013.

FY2025 Net Income−$14.7M▲ +72.4% YoY
Trailing 12M (TTM)−$14.7Mtrailing 4 quarters sum
Net Profit Margin-339.3%−$14.7M ÷ $4.3M
YoY Change+72.4%—
5-Year CAGRN/AN/A — contains loss years
FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0
Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net IncomeNet LossNet Margin %★ First Profit: 2013

▸ FMP /income-statement · Annual · PRPH net income history · PRPH profit margin

Annual net income data

Fiscal YearNet IncomeYoY ChangeNet Margin
FY2025Loss−$14.7M▲ +72.4%-339.3%
FY2024Loss−$53.4M▼ 218.0%-788.2%
FY2023Loss−$16.8M▼ 190.9%-37.8%
FY2022$18.5M▲ +194.3%15.1%
FY2021$6.3M▲ +395.2%7.9%

Net income vs peers (Healthcare)

#CompanyNet IncomeYoY
#1
ProPhase Labs, Inc.
ProPhase Labs, Inc.YOU
PRPH
−$14.7M+72.4%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$26.80B+90.6%#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$20.64B+94.9%#4
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$12.06B-16.3%#5
AbbVie Inc.
AbbVie Inc.
ABBV
$4.23B-1.2%
Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

ProPhase Labs, Inc. (PRPH) reported net income of −$14.7M for FY2025 (fiscal year ending 2025-12-31), up 72.4% year-over-year. The net profit margin was -339.3% — meaning the company kept $-3.39 of every dollar of revenue as profit.

Based on available data, ProPhase Labs, Inc. has been profitable since at least 2013. Net income reached a peak of $41.8M in FY2017. Data available for 15 fiscal years.

ProPhase Labs, Inc.'s net profit margin was -339.3% for FY2025, based on the latest annual results.

Investors sometimes search for "ProPhase Labs, Inc. net worth" — the company's market capitalization is a separate figure from PRPH net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.
RevenueFinancial statementsEarningsForecastPrice historyMarket capFree cash flow

Frequently asked questions

PRPH net income · 4 questions

ProPhase Labs, Inc. is not currently profitable on an annual basis. The company reported a net loss of $14.7M for FY2025.

is PRPH profitabledoes PRPH make a profitPRPH profitabilityPRPH profitable company

▸ Source: FMP /income-statement · GAAP · ProPhase Labs, Inc. · ProPhase Labs, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026